Literature DB >> 26909230

Esophageal testing: What we have so far.

Nicola de Bortoli1, Irene Martinucci1, Lorenzo Bertani1, Salvatore Russo1, Riccardo Franchi1, Manuele Furnari1, Salvatore Tolone1, Giorgia Bodini1, Valeria Bolognesi1, Massimo Bellini1, Vincenzo Savarino1, Santino Marchi1, Edoardo Vincenzo Savarino1.   

Abstract

Gastroesophageal reflux disease (GERD) is a common disorder of the gastrointestinal tract. In the last few decades, new technologies have evolved and have been applied to the functional study of the esophagus, allowing for the improvement of our knowledge of the pathophysiology of GERD. High-resolution manometry (HRM) permits greater understanding of the function of the esophagogastric junction and the risks associated with hiatal hernia. Moreover, HRM has been found to be more reproducible and sensitive than conventional water-perfused manometry to detect the presence of transient lower esophageal sphincter relaxation. Esophageal 24-h pH-metry with or without combined impedance is usually performed in patients with negative endoscopy and reflux symptoms who have a poor response to anti-reflux medical therapy to assess esophageal acid exposure and symptom-reflux correlations. In particular, esophageal 24-h impedance and pH monitoring can detect acid and non-acid reflux events. EndoFLIP is a recent technique poorly applied in clinical practice, although it provides a large amount of information about the esophagogastric junction. In the coming years, laryngopharyngeal symptoms could be evaluated with up and coming non-invasive or minimally invasive techniques, such as pepsin detection in saliva or pharyngeal pH-metry. Future studies are required of these techniques to evaluate their diagnostic accuracy and usefulness, although the available data are promising.

Entities:  

Keywords:  BRAVO; EndoFLIP; Gastroesophageal reflux disease; High resolution manometry; Multichannel impedance and pH; PEP-test; Restech

Year:  2016        PMID: 26909230      PMCID: PMC4753191          DOI: 10.4291/wjgp.v7.i1.72

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  122 in total

Review 1.  Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.

Authors:  Daniel Sifrim; Frank Zerbib
Journal:  Gut       Date:  2012-06-08       Impact factor: 23.059

2.  Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.

Authors:  E Savarino; L Gemignani; D Pohl; P Zentilin; P Dulbecco; L Assandri; E Marabotto; D Bonfanti; S Inferrera; V Fazio; A Malesci; R Tutuian; V Savarino
Journal:  Aliment Pharmacol Ther       Date:  2011-06-14       Impact factor: 8.171

3.  Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.

Authors:  I Mainie; R Tutuian; A Agrawal; D Adams; D O Castell
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

Review 4.  Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease.

Authors:  G E Boeckxstaens; A Smout
Journal:  Aliment Pharmacol Ther       Date:  2010-05-18       Impact factor: 8.171

5.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

6.  Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing.

Authors:  Steven S Shay; Steven Bomeli; Joel Richter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

7.  Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients.

Authors:  Edoardo Savarino; Roberto Carbone; Elisa Marabotto; Manuele Furnari; Luca Sconfienza; Massimo Ghio; Patrizia Zentilin; Vincenzo Savarino
Journal:  Eur Respir J       Date:  2013-03-07       Impact factor: 16.671

8.  Wireless pH monitoring in patients with non-cardiac chest pain.

Authors:  Chandra Prakash; Ray E Clouse
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

9.  Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests?

Authors:  Michael F Vaezi
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

Review 10.  Dysmotility and reflux disease.

Authors:  Edoardo Savarino; Maria Giacchino; Vincenzo Savarino
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2013-12       Impact factor: 2.064

View more
  4 in total

1.  Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.

Authors:  In Kyung Yoo; Weon Jin Ko; Hak Su Kim; Hee Kyung Kim; Jung Hyun Kim; Won Hee Kim; Sung Pyo Hong; Abdullah Özgür Yeniova; Joo Young Cho
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  New Approaches to Gastroesophageal Reflux Disease.

Authors:  William Kethman; Mary Hawn
Journal:  J Gastrointest Surg       Date:  2017-06-16       Impact factor: 3.452

3.  The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.

Authors:  Xing Du; Feng Wang; Zhiwei Hu; Jimin Wu; Zhonggao Wang; Chao Yan; Chao Zhang; Juan Tang
Journal:  BMC Gastroenterol       Date:  2017-10-17       Impact factor: 3.067

4.  Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms.

Authors:  Željko Zubčić; Tihana Mendeš; Andrijana Včeva; Hrvoje Mihalj; Vjeran Bogović; Stjepan Grga Milanković
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.